Cellular mechanisms and consequences of glycation in atherosclerosis and obesity
- PMID: 27166197
- PMCID: PMC5101176
- DOI: 10.1016/j.bbadis.2016.05.005
Cellular mechanisms and consequences of glycation in atherosclerosis and obesity
Abstract
Post-translational modification of proteins imparts diversity to protein functions. The process of glycation represents a complex set of pathways that mediates advanced glycation endproduct (AGE) formation, detoxification, intracellular disposition, extracellular release, and induction of signal transduction. These processes modulate the response to hyperglycemia, obesity, aging, inflammation, and renal failure, in which AGE formation and accumulation is facilitated. It has been shown that endogenous anti-AGE protective mechanisms are thwarted in chronic disease, thereby amplifying accumulation and detrimental cellular actions of these species. Atop these considerations, receptor for advanced glycation endproducts (RAGE)-mediated pathways downregulate expression and activity of the key anti-AGE detoxification enzyme, glyoxalase-1 (GLO1), thereby setting in motion an interminable feed-forward loop in which AGE-mediated cellular perturbation is not readily extinguished. In this review, we consider recent work in the field highlighting roles for glycation in obesity and atherosclerosis and discuss emerging strategies to block the adverse consequences of AGEs. This article is part of a Special Issue entitled: The role of post-translational protein modifications on heart and vascular metabolism edited by Jason R.B. Dyck & Jan F.C. Glatz.
Keywords: Atherosclerosis; Diabetes; Glycation; Obesity; Receptor for advanced glycation end products; Theraepeutics.
Copyright © 2016 Elsevier B.V. All rights reserved.
Figures


Similar articles
-
Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels.Life Sci. 2020 Oct 1;258:118196. doi: 10.1016/j.lfs.2020.118196. Epub 2020 Aug 5. Life Sci. 2020. PMID: 32763295
-
Advanced glycation end products in the pathogenesis of chronic kidney disease.Kidney Int. 2018 Apr;93(4):803-813. doi: 10.1016/j.kint.2017.11.034. Epub 2018 Feb 22. Kidney Int. 2018. PMID: 29477239 Review.
-
The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.Curr Protein Pept Sci. 2020;21(9):846-859. doi: 10.2174/1389203721666200505101734. Curr Protein Pept Sci. 2020. PMID: 32368974 Review.
-
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Int J Biochem Cell Biol. 2016 Dec;81(Pt B):403-418. doi: 10.1016/j.biocel.2016.06.016. Epub 2016 Jun 29. Int J Biochem Cell Biol. 2016. PMID: 27373680 Review.
-
Glycation & the RAGE axis: targeting signal transduction through DIAPH1.Expert Rev Proteomics. 2017 Feb;14(2):147-156. doi: 10.1080/14789450.2017.1271719. Epub 2016 Dec 22. Expert Rev Proteomics. 2017. PMID: 27967251 Free PMC article. Review.
Cited by
-
Transcriptome sequencing of 3,3',4,4',5-Pentachlorobiphenyl (PCB126)-treated human preadipocytes demonstrates progressive changes in pathways associated with inflammation and diabetes.Toxicol In Vitro. 2022 Sep;83:105396. doi: 10.1016/j.tiv.2022.105396. Epub 2022 May 23. Toxicol In Vitro. 2022. PMID: 35618242 Free PMC article.
-
Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation.Nutr Metab (Lond). 2023 Nov 23;20(1):51. doi: 10.1186/s12986-023-00770-z. Nutr Metab (Lond). 2023. PMID: 37996895 Free PMC article.
-
RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease.Int J Endocrinol. 2019 Sep 18;2019:2151302. doi: 10.1155/2019/2151302. eCollection 2019. Int J Endocrinol. 2019. PMID: 31641351 Free PMC article. Review.
-
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.Front Endocrinol (Lausanne). 2021 Mar 11;12:636267. doi: 10.3389/fendo.2021.636267. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33776930 Free PMC article. Review.
-
S100 proteins in obesity: liaisons dangereuses.Cell Mol Life Sci. 2020 Jan;77(1):129-147. doi: 10.1007/s00018-019-03257-4. Epub 2019 Jul 30. Cell Mol Life Sci. 2020. PMID: 31363816 Free PMC article. Review.
References
-
- Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 1995;34:10872–10878. - PubMed
-
- Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21:3–12. doi: 10.1097/01.hjh.0000042892.24999.92. - PubMed
-
- Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed MU, Reddy S, Zyzak DV, Thorpe SR, Baynes JW. New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant. 1996;11(Suppl 5):41–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous